secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2021-12-10T23:59:59+00:00
Accession:  0001104659-21-148566
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical Q3 2021 net revenue $19.6M (+108% YoY); non-GAAP net income $3.5M
--------------------------------------------------------------------------------

- Net revenue $19.6M vs $9.4M in Q3 2020, up 108%.
- Non-GAAP net income $3.5M ($0.38 basic EPS) vs $0.6M in Q3 2020.
- Completed November IPO: 3.52M shares at $10, net proceeds $31.2M.
- New CFO appointed; DFD-29 Phase 3 first dosing expected Q1 2022.
- Cash and equivalents $21.7M as of Sep 30, 2021, up from $8.2M at Dec 31, 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465921148566/0001104659-21-148566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465921148566/tm2135030d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-148566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer